Instead, its viewed as an experimental option that still requires more research to determine if its effective and safe enough to become a standard ADHD treatment
Headache, Dizziness, or Fatigue Some individuals may experience mild headaches, dizziness, or fatigue following the injection
Bahne E, Sun EW, Young RL, Hansen M, Sonne DP, Hansen JS, et al
Currently prescribed aspirin and pantoprazole which decrease conversion of vitamin C to its active form
Immediate medical attention is necessary if bloating is accompanied by: Severe, persistent, or worsening abdominal pain that does not resolve with position changes or over-the-counter remedies Inability to pass gas or have bowel movements, suggesting possible bowel obstruction Persistent vomiting, particularly if unable to tolerate oral fluids, raising concern for gastroparesis or pancreatitis Signs of dehydration (dizziness, reduced urination, dark urine) Fever, which may indicate infection or inflammation Bloody or black tarry stools Right upper quadrant pain or jaundice (yellowing of skin or eyes), which may suggest gallbladder disease Unintentional rapid weight loss beyond expected therapeutic effects Patients should stop tirzepatide and contact their healthcare provider immediately if they experience severe or persistent abdominal pain, with or without vomiting, as these may be symptoms of acute pancreatitis
This triple mechanism of action distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)
